0001213900-23-075010.txt : 20230907 0001213900-23-075010.hdr.sgml : 20230907 20230907163210 ACCESSION NUMBER: 0001213900-23-075010 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230905 FILED AS OF DATE: 20230907 DATE AS OF CHANGE: 20230907 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ryan John L CENTRAL INDEX KEY: 0001679825 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40582 FILM NUMBER: 231242674 MAIL ADDRESS: STREET 1: C/O KADMON HOLDINGS, LLC STREET 2: 450 E. 29TH STREET CITY: NEW YORK STATE: NY ZIP: 10016 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Unicycive Therapeutics, Inc. CENTRAL INDEX KEY: 0001766140 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 813638692 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4300 EL CAMINO REAL, SUITE 210 CITY: LOS ALTOS STATE: CA ZIP: 94022 BUSINESS PHONE: 650-384-0642 MAIL ADDRESS: STREET 1: 4300 EL CAMINO REAL, SUITE 210 CITY: LOS ALTOS STATE: CA ZIP: 94022 4 1 ownership.xml OWNERSHIP DOCUMENT X0508 4 2023-09-05 0 0001766140 Unicycive Therapeutics, Inc. UNCY 0001679825 Ryan John L C/O UNICYCIVE THERAPEUTICS, INC. 4300 EL CAMINO REAL SUITE 210 LOS ALTOS CA 94022 1 0 0 0 0 Stock Options 0.76 2023-09-05 4 A 0 112147 0 A 2033-09-05 Common Stock 112147 123775 D 37,382 options vest on June 26, 2024, 37,382 options vest on June 26, 2025 and 37,383 vest on June 26, 2026. /s/ John Ryan 2023-09-07